Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer
Theranostics · 2026
DOI: 10.7150/thno.125878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Yongkang Qiu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Zirconium, Radioisotopes, B7 Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
- Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China, Beijing 100034, China.
- Departments of Radiology and Medical Physics, University of Wisconsin - Madison, Madison, WI 53705, USA.
Zitieren
APA
Qiu, Y., Gu, T., Wang, T., Mulati, Y., Sun, X., Yang, Q., Song, L., Yuan, T., Fan, Y., Kang, L., & Cai, W. (2026). Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer. Theranostics. https://doi.org/10.7150/thno.125878
Vancouver
Qiu Y, Gu T, Wang T, Mulati Y, Sun X, Yang Q, et al. Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer. Theranostics. 2026. doi:10.7150/thno.125878
BibTeX
@article{Qiu2026,
author = {Qiu, Yongkang and Gu, Tingfei and Wang, Tianyao and Mulati, Yelin and Sun, Xinyao and Yang, Qi and Song, Lele and Yuan, Tingting and Fan, Yu and Kang, Lei and Cai, Weibo},
title = {Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.125878}
}
EUVIMED